{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"76.500","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2024","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"1,227,863,545","primaryexch":"HKEX","ric":"2268.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.8925,"inline_upper_strike_price":"","sedol":"BQHNQ38","am":"259.87","iv":"","ew_strike":"","as":"74.550","geographic_focus":null,"incorpin":"Cayman Islands","etp_baseCur":null,"ew_amt_os":"","bd":"74.500","registrar":"Computershare Hong Kong Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-09-26 10:38:37.0","lo52":"18.520","shares_issued_date":"10 Sep 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"Zhisheng Chen","underlying_ric":"2268.HK","hi52":"78.550","issuer_name":"WuXi XDC Cayman Inc.","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"26 Sep 2025 16:08","aum_date":"","lo":"73.000","mkt_cap":"91.47","f_aum_hkd":null,"ew_sub_per_to":"","ls":"74.500","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"-2.250","aum":"","issued_shares_class_B":null,"vo":"3.47","secondary_listing_flag":false,"listing_date":"17 Nov 2023","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"WuXi XDC Cayman Inc.","nm_s":"WUXI XDC","sym":"2268","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.050","strike_price":"","summary":"WuXi XDC Cayman Inc is an investment holding company principally engaged in the provision of comprehensive contract research, development and manufacturing organization (CRDMO) services for antibody drug conjugate (ADC) and other bioconjugates. The Company's services include the discovery, process development and Good Manufacturing Practice (GMP) manufacturing for bioconjugates, monoclonal antibody intermediates and payload-linkers associated with bioconjugates. The Company provides CRDMO services to customers through contracts under fee-for-service (FFS) basis and contracts under full-time equivalent (FTE) basis. The Company principally conducts its businesses in domestic and overseas markets, including North America, Europe and the rest of the world.","op":"74.950","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Biotechnology","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"31/F, Tower Two<br/>Times Square<br/>1 Matheson Street<br/>Causeway Bay, Hong Kong","pc":"-2.93","days_to_expiry":null,"underlying_code":null,"pe":"78.78","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"76.750","isin":"KYG9808A1058","moneyness":""}},"qid":"1758890061704"}
